Velsera

Medicine moves too slow. At Velsera, we are changing that. Velsera was formed in 2023 through the shared vision of Seven Bridges and Pierian, with a mission to accelerate the discovery, development, and delivery of life-changing insights. Velsera provides software and professional services for: AI-powered multimodal data harmonization and analytics for drug discovery and development IVD development, validation, and regulatory approval Clinical NGS interpretation, reporting, and adoption With our headquarters in Boston, MA, we are growing and expanding our teams located in different countries!

Medicine moves too slow. At Velsera, we are changing that. Velsera was formed in 2023 through the shared vision of Seven Bridges and Pierian, with a mission to accelerate the discovery, development, and delivery of life-changing insights. Velsera provides software and professional services for: AI-powered multimodal data harmonization and analytics for drug discovery and development IVD development, validation, and regulatory approval Clinical NGS interpretation, reporting, and adoption With our headquarters in Boston, MA, we are growing and expanding our teams located in different countries!

Related companies:

🏢 Natera
👥 1001-5000💰 $250,000,000 Post-IPO Equity over 2 years ago🫂 Last layoff almost 3 years agoWomen'sBiotechnologyMedicalGeneticsHealth Diagnostics
Website LinkedIn Email Facebook Twitter

Jobs at this company:

United StatesFull-TimeBiomedical Data AnalysisPosted 28 days ago
LeadershipProject ManagementSoftware Development+7 more